We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$144M
Cap. Flow %
3.24%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
3.7 years
Avg Time Held Equity only
4.6 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
3.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.84%
2 Technology 15.96%
3 Healthcare 9.75%
4 Financials 7.52%
5 Communication Services 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EHAB icon
3476
DELISTED
Enhabit
EHAB
$9 ﹤0.01%
1
– –
2022 Q3
10 quarters
AVTX icon
3477
Avalo Therapeutics
AVTX
$655M
$8 ﹤0.01%
1
– –
2020 Q1
20 quarters
HOS icon
3478
Hornbeck Offshore Services, Inc.
HOS
$2.19B
$8 ﹤0.01%
1
– –
2021 Q2
15 quarters
ABVEW
3479
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$7 ﹤0.01%
300
– –
2024 Q3
2 quarters
AVAL icon
3480
Grupo Aval
AVAL
$5.82B
$6 ﹤0.01%
2
– –
2019 Q1
24 quarters
KALA icon
3481
KALA BIO
KALA
$3.77M
– –
0
– –
2021 Q1
16 quarters
ITDD icon
3482
iShares LifePath Target Date 2040 ETF
ITDD
$122M
– –
0
– –
2025 Q1
0 quarters
ALZN icon
3483
Alzamend Neuro
ALZN
$6.27M
– –
0
– –
2023 Q4
5 quarters
IMUX icon
3484
Immunic
IMUX
$97M
– –
0
– –
2018 Q2
27 quarters
CUTR icon
3485
DELISTED
Cutera, Inc.
CUTR
$2 ﹤0.01%
150
– –
2022 Q2
11 quarters
CCO icon
3486
Clear Channel Outdoor Holdings
CCO
$1.23B
$1 ﹤0.01%
1
– –
2023 Q2
7 quarters
XXII
3487
22nd Century Group
XXII
$444K
– –
0
– –
2018 Q2
27 quarters
NKLA icon
3488
DELISTED
Nikola Corporation Common Stock
NKLA
$1 ﹤0.01%
5
– –
2020 Q3
18 quarters
AAXJ icon
3489
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.75B
– –
-36
Closed -$2.6K –
ADV icon
3490
Advantage Solutions
ADV
$377M
– –
-3
Closed -$184 –
AHCO icon
3491
AdaptHealth
AHCO
$851M
– –
-63
Closed -$600 –
AKO.B icon
3492
Embotelladora Andina Series B
AKO.B
$4.57B
– –
-1
Closed -$18 –
OSG icon
3493
Octave Specialty Group
OSG
$208M
– –
-61
Closed -$772 –
AMCX icon
3494
AMC Global Media
AMCX
$445M
– –
-3,076
Closed -$30.5K –
ANIP icon
3495
ANI Pharmaceuticals
ANIP
$1.66B
– –
-36
Closed -$1.99K –
APGE icon
3496
DELISTED
Apogee Therapeutics
APGE
– –
-6
Closed -$272 –
ARAY icon
3497
Accuray
ARAY
$19.4M
– –
-40,000
Closed -$79.2K –
ARKQ icon
3498
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.82B
– –
-70
Closed -$5.41K –
ATLC icon
3499
Atlanticus Holdings
ATLC
$1.41B
– –
-7
Closed -$390 –
AVAH icon
3500
Aveanna Healthcare
AVAH
$2.74B
– –
-20
Closed -$91 –

Similar funds

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.